Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemours (CC) Payables (2016 - 2025)

Historic Payables for Chemours (CC) over the last 12 years, with Q3 2025 value amounting to $1.0 billion.

  • Chemours' Payables fell 398.89% to $1.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year decrease of 398.89%. This contributed to the annual value of $1.2 billion for FY2024, which is 25.88% down from last year.
  • According to the latest figures from Q3 2025, Chemours' Payables is $1.0 billion, which was down 398.89% from $1.0 billion recorded in Q2 2025.
  • Chemours' Payables' 5-year high stood at $1.3 billion during Q3 2022, with a 5-year trough of $885.0 million in Q3 2023.
  • In the last 5 years, Chemours' Payables had a median value of $1.1 billion in 2024 and averaged $1.1 billion.
  • In the last 5 years, Chemours' Payables skyrocketed by 6298.0% in 2021 and then plummeted by 3031.5% in 2023.
  • Quarter analysis of 5 years shows Chemours' Payables stood at $1.2 billion in 2021, then rose by 6.11% to $1.2 billion in 2022, then fell by 6.0% to $1.2 billion in 2023, then decreased by 0.26% to $1.2 billion in 2024, then decreased by 10.47% to $1.0 billion in 2025.
  • Its last three reported values are $1.0 billion in Q3 2025, $1.0 billion for Q2 2025, and $1.0 billion during Q1 2025.